Search Results - "Verheijden, Rik Jasper"

Association between physical activity, immune-related adverse events, and mortality in patients undergoing immune checkpoint inhibition by Verheijden, Rik Jasper, Cabane Ballester, Anna, van Eijs, Mick JM, van Lindert, Anne SR, Suijkerbuijk, Karijn, May, Anne Maria

“…2643 Background: Immune checkpoint inhibitors (ICIs) have improved prospects for some, but not all patients with cancer and frequently induce severe…”
Get full text

The impact of frailty on the occurrence of immune-related adverse events in older patients with advanced melanoma by Bruijnen, Cheryl P., Koldenhof, Josephine J, Tonk, Erwin H.J., Verheijden, Rik Jasper, van den Bos, Frederiek, Emmelot- Vonk, Mariëlle H., Witteveen, Petronella, Suijkerbuijk, Karijn

“…Abstract only e24028 Background: Immune checkpoint inhibitors (ICIs) have changed the melanoma treatment landscape by inducing durable responses and…”
Get full text

A prediction model for response to immune checkpoint inhibition in advanced melanoma by van Duin, Isabella A.J., Verheijden, Rik Jasper, van Diest, Paul J., van den Eertwegh, Alfonsus Johannes Maria, de Groot, Jan Willem, van Not, Olivier Jules, Aarts, Maureen J.B., Van Den Berkmortel, Franchette, Blank, Christian U., Haanen, John B. A. G., Hospers, Geke, Piersma, Djura, van Rijn, Rozemarijn, Van Der Veldt, Astrid Aplonia Maria, Vreugdenhil, Gerard, Stevense - den Boer, Marion, Boers-Sonderen, Marye J., Kapiteijn, Ellen, Suijkerbuijk, Karijn, Elias, Sjoerd G.

“…9532 Background: Immune checkpoint inhibition (ICI) has greatly improved the prognosis for advanced melanoma in the last decade. However, it is still difficult…”
Get full text

Management of checkpoint inhibitor toxicity and survival in patients with advanced melanoma by van Not, Olivier Jules, Verheijden, Rik Jasper, van den Eertwegh, Alfonsus Johannes Maria, Haanen, John B. A. G., Blank, Christian U., Aarts, Maureen J.B., Van Den Berkmortel, Franchette, de Groot, Jan Willem, Hospers, Geke, Kapiteijn, Ellen, de Meza, Melissa Melanie, Piersma, Djura, Van Rijn, Rozemarijn, Stevense - den Boer, Marion, Van Der Veldt, Astrid Aplonia Maria, Vreugdenhil, Gerard, Boers-Sonderen, Marye J., Blokx, Willeke, Wouters, Michel W.J.M., Suijkerbuijk, Karijn

“…9546 Background: Management of checkpoint-inhibitor-induced immune-related adverse events (irAEs) is primarily based on expert opinion. Recent studies have…”
Get full text